サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血管パッチの世界市場-2023年～2030年
市場調査レポート
商品コード
1319140

血管パッチの世界市場-2023年～2030年

Global Vacular Patches Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管パッチの世界市場-2023年～2030年
出版日: 2023年07月31日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の血管パッチ市場は、2022年に7億米ドルに達し、2023-2030年の予測期間にCAGR 7.6%で成長し、2030年には12億米ドルに達すると予測されています。動脈瘤、動脈狭窄、不要な血栓のような疾患の流行などの要因が、予測期間の市場規模を押し上げます。高齢化人口の増加により、Terumo Corporation、C R Bard Inc、B Braun Melsungen AGなどの重要な競合が存在する北米地域で市場が拡大しています。

血管パッチは、末梢血管の再建、表面ラインのバットレス、その他の修復に使用されます。血管パッチはポリエステルウレタンでできています。パッチに使用される弾性材料は縫合穴からの出血を抑えるのに役立ちます。

市場力学

慢性静脈不全の増加が市場成長を牽引

血管パッチ市場を牽引している主な要因は、慢性静脈不全症例の増加です。多くの人々が慢性静脈不全に苦しんでおり、それが血管手術につながっており、それが市場の成長を牽引しています。例えば、Stats Pearls誌に掲載された記事によると、慢性静脈不全（CVI）は通常、静脈性高血圧に続発する下肢の浮腫、皮膚栄養変化、不快感を指します。慢性静脈不全は有病率の高い疾患です。

慢性静脈不全に関連した障害は、生活の質の低下や仕事の生産性の低下につながります。ほとんどの場合、原因は弁の機能不全です。毎年約15万人の患者が新たに慢性静脈不全と診断され、これらの患者の治療に5億米ドル近くが費やされています。このように、疾患の増加は市場成長の原動力となると思われます。

主要プレーヤーによる主要戦略が市場成長を促進する

主要企業による主要戦略の台頭が市場成長を支配すると思われます。例えば、2022年5月19日、アイルランドを拠点とする血管閉鎖装置企業Vivasureは、一連の投資において、吸収パッチベースの経皮的血管閉鎖技術の臨床開発と規制当局の承認を進めるために約2,500万米ドルを調達しました。血管内治療や心血管系治療で利用される「PerQseal」技術は、合成インプラントを用いて静脈や動脈を内側から密閉します。

他の既存のソリューションがコラーゲン、縫合糸、金属インプラントなどの材料を残すのに対し、Vivasureの合成インプラントは、動脈や静脈を正常な状態に戻すよう設計されており、残存物を残さないです。このように、主要企業の戦略は市場の成長を促進するのに役立っています。

高価な血管処置費用が市場成長の妨げに

血管治療の費用は高額であるため、患者は必要であってもその費用を捻出することができないです。例えば、インドにおける血管手術の平均費用は600～800米ドルで、パッチ単価は未処置の自家心膜で5ドル（米国ドル）、自家移植枝パッチで6,105ドルとなっています。このように、血管処置のコストが高いことは、市場の成長を妨げる可能性があります。

COVID-19影響分析

COVID-19の流行は血管パッチ市場に大きな影響を与え、多くの国に前例のない課題を突きつけています。COVID-19のせいで、外科手術が急速に減少し、手術が延期されています。手術の減少により、血管パッチの使用量は減少しています。そのため、血管パッチ市場にマイナスの影響を与えています。

ロシア・ウクライナ紛争の影響分析

ロシア・ウクライナ紛争は、この地域の主要市場プレーヤーの数が少ないことから、世界の血管パッチ市場に与える影響は中程度と推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界の血管パッチ市場の成長にほとんど影響を与えないと予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 血管疾患の有病率の増加
      • 高齢者の増加
    • 抑制要因
      • 熟練者の不足
    • 機会
      • 治療法の開発
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争分析

第8章 材料タイプ別

  • 自家静脈
  • 牛心膜
  • 合成
    • ポリテトラフルオロエチレン（PTFE）
    • ダクロン

第9章 用途別

  • 頸動脈内膜剥離術
  • 血管バイパス手術
  • その他

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市場シェア分析
  • M&A分析

第13章 企業プロファイル

  • Becton Dickinson and Company
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Terumo Corporation
  • C R Bard, Inc
  • B Braun MelsungenAG
  • LeMaitre Vascular, Inc
  • Admedus, CryoLife, Inc
  • Labcor Laboratorios Ltd
  • Baxter International IncScience.
  • W.L. Gore&Associates, Inc
  • Vascudyne, Inc.

第14章 付録

目次
Product Code: MD1408

Market Overview

Global Vascular System Market reached US$ 0.7 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 7.6% during the forecast period 2023-2030. Factors such as the prevalence of diseases like aneurysms, arterial stenosis, and unwanted blood clots drives the market size in the forecast period. Due to the rise in the number of the aging population, the market is increasing in the North American region with significant competitors like Terumo Corporation, C R Bard Inc, B Braun Melsungen AG, and others.

Vascular patches are used for peripheral vascular reconstruction, surface line buttressing, and other repairs. The patches are also used for femoral, renal, and iliac endarterectomy procedures. vascular patches are made up of polyester urethane. The elastic material used in patches helps to reduce suture hole bleeding.

Market Dynamics

Rising Chronic Venous Insufficiency Will Drive the Market Growth

The major factor that is driving the vascular patches market is the increase in the number of chronic venous insufficiency cases. A number of people are suffering from chronic venous insufficiency, which is leading to vascular surgeries, and that is driving the growth of the market. Rising chronic venous insufficiency will drive market growth, for instance, an article published in Stats Pearls stated that Chronic venous insufficiency (CVI) typically refers to lower extremity edema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency is a prevalent disease.

Disability related to chronic venous insufficiency attributes to diminished quality of life and loss of work productivity. In most cases, the cause is incompetent valves. Each year approximately 150,000 new patients are diagnosed with chronic venous insufficiency, and nearly $500 million is used in the care of these patients. Thus the rise of diseases will drive the market growth.

Key Strategies by the Key Players will Drive the Market Growth

The rise of key strategies by the key players will dominate the market growth. For instance, on May 19, 2022, in a series of investments, Ireland-based vessel closure device firm Vivasure raised about $25 million to advance clinical development and regulatory approval for its absorbable, patch-based, percutaneous vessel-sealing technology. Utilized during endovascular and cardiovascular procedures, the "PerQseal" technology uses a synthetic implant to seal a vein or artery from the inside.

While other existing solutions leave behind materials such as collagen, sutures, or metal implants, Vivasure's synthetic implants were designed to return an artery or vein to its normal state without leaving any remnants behind. Thus the strategies of the key players help to drive the market growth.

Expensive Cost of Vascular Procedures will Hamper the Market Growth

Due to the expensive cost of vascular procedures, patients could not afford them even if required. For instance, the average cost of vascular surgery in India ranges from US$600-US$800, and the cost per unit patch ranges from $5 (dollars, US) for untreated autologous pericardium to $6,105 for homograft branch patch. Thus high cost of vascular procedures can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the vascular patches market, posing unprecedented challenges to many countries. Due to COVID-19, there is a rapid decrease in surgical procedures, and the surgeries have been postponed. Due to the reduction insurgeries, the usage of vascular patches has been reduced. Thus, it has negatively impacted the vascular patch market.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global vascular patches market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global vascular patches market growth over the forecast period.

Segment Analysis

The global vascular patches market is segmented based on material type, application, and end user.

The Carotid Endarterectomy Segment Holds the Dominant Position in the Market Over Forecast Period with 56.4% share.

Carotid Endarterectomyholds the most significant market share.Carotid endarterectomy is a surgical procedure to remove a build-up of fatty deposits (plaque), which cause the narrowing of a carotid artery. The carotid arteries are the main blood vessels that supply blood to the neck, face, and brain.

Carotid endarterectomy (CEA) is among the most frequently performed vascular operations in the United States. For instance, according to the Journal of Vascular Surgeries, more than 100,000 such operations are performed annually at a cost of $1.2 billion. Thus increase in the number of carotid endarterectomy surgeries is holding the carotid endarterectomy in the top position.

Geographical Analysis

Asia Pacific Accounted for 23.7% of the Market Share Owing to the Prevalence of Diseases

Due to the increasing penetration of commercial providers in this region and the expanding launch of plans by central and state governments. Furthermore, the rising frequency of chronic diseases and densely populated nations such as China and India would drive market expansion in the vascular patches market.

Cardiovascular diseases (CVDs), the world's leading cause of death, claim as many as 17.9 million lives each year globally. According to a study by the Indian Council of Medical Research and Registrar General of India, India accounts for approximately 60 percent of the world's heart disease burden.

Competitive Landscape

The major global players in the global vascular patches market include: Becton, Dickinson and Company; Terumo Corporation; C R Bard, Inc; B Braun MelsungenAG; LeMaitre Vascular, Inc; Admedus; CryoLife, Inc; LabcorLaboratorios Ltd; Baxter International IncScience among others.

Why Purchase the Report?

  • To visualize the global vascular patches market segmentation based on material type, application, end-user, and region,as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vascular patches market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vascular patches market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the prevalence of vascular diseases
      • 4.1.1.2. An increase in the number of elderly aging people
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of skilled individuals
    • 4.1.3. Opportunity
      • 4.1.3.1. Developments in the treatment methods
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Autologous vein
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Bovine pericardium
  • 8.4. Synthetic
    • 8.4.1. Polytetrafluoroethylene (PTFE)
    • 8.4.2. Dacron

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Carotid endarterectomy
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Vascular bypass surgery
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. The U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. The U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Italy
      • 11.3.6.5. Spain
      • 11.3.6.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Brazil
      • 11.4.6.2. Argentina
      • 11.4.6.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. Australia
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Becton Dickinson and Company
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Terumo Corporation
  • 13.3. C R Bard, Inc
  • 13.4. B Braun MelsungenAG
  • 13.5. LeMaitre Vascular, Inc
  • 13.6. Admedus, CryoLife, Inc
  • 13.7. Labcor Laboratorios Ltd
  • 13.8. Baxter International IncScience.
  • 13.9. W.L. Gore&Associates, Inc
  • 13.10. Vascudyne, Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us